Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has emerged as one of the most studied weight loss medications in modern medicine. Clinical trials consistently demonstrate that patients taking semaglutide lose significantly more weight than those on diet and exercise alone—but the exact amount varies based on your genetics, starting weight, and commitment to the protocol. PlexusDx compounded semaglutide injections start at $149 per month, offering access without insurance or membership requirements.

Average Semaglutide Weight Loss Results From Clinical Trials

The landmark STEP trials, which enrolled over 4,500 adults with obesity, revealed that participants receiving semaglutide 2.4 mg weekly lost an average of 15% of their body weight over 68 weeks. This translates to approximately 35 pounds for someone starting at 230 pounds, though individual results ranged from minimal loss to over 50 pounds in high responders. The control group taking placebo lost only 2-3% of body weight during the same period, underscoring semaglutide's potency.

Weight loss typically follows a predictable timeline: most patients see their first measurable reductions between weeks 4-8, with the steepest losses occurring between months 3-6. After six months, the rate of weight loss often plateaus, meaning your body stabilizes at a lower weight rather than continuing to drop pounds indefinitely. This plateau is physiologically normal and reflects how the medication works—it reduces hunger and increases satiety, creating lasting behavioral shifts rather than continuous weight decline.

Factors That Influence Your Individual Semaglutide Weight Loss

Your genetics play a measurable role in how much weight you lose on semaglutide. Specific variants in genes like GLP1R, GIPR, and FTO affect how your body responds to the medication and how efficiently you metabolize glucose and fat. PlexusDx offers the Precision Peptide Genetic Test ($99 after your first month of treatment), which maps 14 metabolic pathways and 49 peptides to reveal your individual predispositions and optimize your protocol for maximum effectiveness.

Lifestyle factors amplify semaglutide's impact dramatically. Patients who combine the medication with consistent physical activity, adequate protein intake, and hydration lose significantly more weight than those relying on semaglutide alone. Your starting weight also influences percentage-based loss—someone starting at 250 pounds will typically lose more total pounds than someone starting at 180 pounds on the same dose, though both may achieve similar percentage reductions.

Realistic Weight Loss Expectations at Different Dose Levels

Semaglutide dosing starts at 0.25 mg weekly and escalates gradually to a maintenance dose, typically 2.4 mg weekly. Many patients experience noticeable appetite suppression and initial weight loss at lower doses (0.5-1.0 mg), though the most substantial reductions occur at therapeutic doses of 1.7-2.4 mg. Your dose may need to go up as your body adjusts—your price won't. PlexusDx keeps your monthly cost flat regardless of dose adjustments, eliminating financial barriers to reaching your optimal therapeutic level.

Some patients reach their goal weight before reaching the maximum dose, while others benefit from titrating to the full 2.4 mg weekly. The relationship between dose and weight loss is not perfectly linear—doubling your dose does not guarantee double the weight loss. Your body's response depends on receptor sensitivity, metabolic rate, and how consistently you use the medication as prescribed.

How Semaglutide Compares to Diet Alone and Other Weight Loss Approaches

Fad diets and calorie restriction produce short-term weight loss but frequently result in weight regain because they do not address the hormonal and neurological factors driving hunger and appetite. Semaglutide works differently—it directly targets GLP-1 receptors in the brain's appetite center and slows gastric emptying, creating genuine physiological changes that persist as long as you take the medication. This mechanism explains why semaglutide produces sustainable weight loss rather than the yo-yo cycle associated with willpower-dependent diets.

Compared to other weight loss medications like phentermine (a stimulant used short-term), semaglutide produces greater total weight loss and is approved for long-term use. Its safety profile in clinical trials was favorable, with the most common side effects being nausea in the first weeks—typically mild and diminishing as your body adapts. PlexusDx compounds semaglutide in licensed 503A pharmacies, ensuring pharmaceutical-grade purity and potency without FDA-approval requirements.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose weight immediately after starting semaglutide?

Most patients notice appetite suppression within days, but measurable weight loss typically appears between weeks 4-8 as your body adjusts to the medication. Initial weight loss is often rapid due to reduced calorie intake and water loss, then stabilizes into steady fat loss of 1-2 pounds weekly at therapeutic doses.

How much weight did people lose in the STEP clinical trials?

Participants receiving semaglutide 2.4 mg weekly lost an average of 15% of their starting body weight (approximately 35 pounds for a 230-pound person) over 68 weeks. High responders lost over 50 pounds, while some patients experienced more modest reductions of 10-15 pounds, demonstrating significant individual variability.

What happens to my weight after I stop taking semaglutide?

Research shows that patients who discontinue semaglutide gradually regain weight over several months as appetite and hunger hormones return to baseline. This is why semaglutide is considered a long-term treatment—stopping the medication reverses the physiological changes it created. Some patients maintain weight loss through sustained lifestyle ...

Does PlexusDx charge more if I need a higher dose?

No. PlexusDx charges a flat monthly rate starting at $149 for compounded semaglutide injections, regardless of your dose level. Your dose may need to go up as your body adjusts to therapeutic levels—your price won't increase.

Can genetic testing predict how much weight I'll lose?

The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your metabolic response to semaglutide. While genetics do not guarantee a specific weight loss number, understanding your peptide pathways allows your provider to optimize your protocol for your unique biology, potentially improving...

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies that meet strict pharmaceutical standards. Compounded and brand medications contain the same active ingredient and produce equivalent clinical effects when dosed identically. The main difference is cost and accessibility—PlexusDx serves all 50 states without insurance.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves